From efficacy to equity: ensuring global access to twice-yearly lenacapavir for HIV prevention
Twice-yearly lenacapavir is a major biomedical advance, but clinical efficacy alone will not deliver population-level HIV prevention impact. The immediate policy challenge is to convert exceptional...
Authors
- Mohamed Abdirahim Omar (ORCID: https://orcid.org/0009-0003-5933-3846)
- Ilyas Abdullahi Khalif (ORCID: https://orcid.org/0009-0002-7421-8638)
- Xaawo Muxumed Maxamed (ORCID: https://orcid.org/0009-0006-5213-8249)
Institutions
- Somali National University (SO)
- Salaam University
Publication Details
- Journal
- Scandinavian Journal of Infectious Diseases
- Published
- 2026-10-13
- DOI
- https://doi.org/10.1080/23744235.2026.2746337
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00